Replimune (REPL) Other Non-Current Liabilities (2018 - 2026)
Replimune (REPL) reported Other Non-Current Liabilities of $455000.0 for Q1 2026, down 51.65% on a YoY basis from $941000.0 in Q1 2025, and down 34.34% sequentially from $693000.0 in Q4 2025.
Replimune (REPL) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Replimune (REPL) has 5 years of Other Non-Current Liabilities data on file, last reported at $455000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities fell 51.65% year-over-year to $455000.0; the trailing twelve-month figure through Mar 2026 stood at $455000.0 (down 51.65% YoY), and the FY2026 full-year result was $455000.0, down 51.65% from the prior year.
- Other Non-Current Liabilities eased to $455000.0 in Q1 2026, from $693000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $1.3 million in Q4 2024 to a low of $455000.0 in Q1 2026.
- A 4-year average of $762307.7 and a median of $786000.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities jumped 66.53% in 2024 and slumped 51.65% in 2026, its largest moves.
- Tracing REPL's Other Non-Current Liabilities over 4 years: stood at $793000.0 in 2023, then soared by 59.65% to $1.3 million in 2024, then sank by 45.26% to $693000.0 in 2025, then plunged by 34.34% to $455000.0 in 2026.
- Business Quant data shows REPL's Other Non-Current Liabilities at $455000.0 in Q1 2026, $693000.0 in Q4 2025, and $941000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 455,000.00 |
| Dec 31, 2025 | 693,000.00 |
| Sep 30, 2025 | 941,000.00 |
| Jun 30, 2025 | 941,000.00 |
| Mar 31, 2025 | 941,000.00 |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 786,000.00 |
| Jun 30, 2024 | 786,000.00 |
| Mar 31, 2024 | 786,000.00 |
| Dec 31, 2023 | 793,000.00 |
| Sep 30, 2023 | 472,000.00 |
| Jun 30, 2023 | 578,000.00 |
| Mar 31, 2023 | 472,000.00 |
| Jun 30, 2018 | 7.09 Mn |
| Mar 31, 2018 | 1.64 Mn |